Tags

Type your tag names separated by a space and hit enter

A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe.
Eur J Cancer 2005; 41(14):2141-9EJ

Abstract

A large European case-control study investigated the association between sunbed use and cutaneous melanoma in an adult population aged between 18 and 49 years. Between 1999 and 2001 sun and sunbed exposure was recorded in 597 newly diagnosed melanoma cases and 622 controls in Belgium, France, The Netherlands, Sweden and the UK. Fifty three percent of cases and 57% of controls ever used sunbeds. The overall adjusted odds ratio (OR) associated with ever sunbed use was 0.90 (95% CI: 0.71-1.14). There was a South-to-North gradient with high prevalence of sunbed exposure in Northern Europe and lower prevalence in the South (prevalence of use in France 20%, OR: 1.19 (0.68-2.07) compared to Sweden, prevalence 83%, relative risk 0.62 (0.26-1.46)). Dose and lag-time between first exposure to sunbeds and time of study were not associated with melanoma risk, neither were sunbathing and sunburns (adjusted OR for mean number of weeks spent in sunny climates >14 years: 1.12 (0.88-1.43); adjusted OR for any sunburn >14 years: 1.16 (0.9-1.45)). Host factors such as numbers of naevi and skin type were the strongest risk indicators for melanoma. Public health campaigns have improved knowledge regarding risk of UV-radiation for skin cancers and this may have led to recall and selection biases in both cases and controls in this study. Sunbed exposure has become increasingly prevalent over the last 20 years, especially in Northern Europe but the full impact of this exposure on skin cancers may not become apparent for many years.

Authors+Show Affiliations

Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Queen Mary, London, UK. veronique.bataille@cancer.org.ukNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

16125927

Citation

Bataille, Véronique, et al. "A Multicentre Epidemiological Study On Sunbed Use and Cutaneous Melanoma in Europe." European Journal of Cancer (Oxford, England : 1990), vol. 41, no. 14, 2005, pp. 2141-9.
Bataille V, Boniol M, De Vries E, et al. A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. Eur J Cancer. 2005;41(14):2141-9.
Bataille, V., Boniol, M., De Vries, E., Severi, G., Brandberg, Y., Sasieni, P., ... Autier, P. (2005). A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. European Journal of Cancer (Oxford, England : 1990), 41(14), pp. 2141-9.
Bataille V, et al. A Multicentre Epidemiological Study On Sunbed Use and Cutaneous Melanoma in Europe. Eur J Cancer. 2005;41(14):2141-9. PubMed PMID: 16125927.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. AU - Bataille,Véronique, AU - Boniol,Mathieu, AU - De Vries,Esther, AU - Severi,Gianluca, AU - Brandberg,Yvonne, AU - Sasieni,Peter, AU - Cuzick,Jack, AU - Eggermont,Alexander, AU - Ringborg,Ulrik, AU - Grivegnée,André-Robert, AU - Coebergh,Jan Willem, AU - Chignol,Marie Christine, AU - Doré,Jean-François, AU - Autier,Philippe, PY - 2004/12/17/received PY - 2005/04/05/revised PY - 2005/04/11/accepted PY - 2005/8/30/pubmed PY - 2005/12/13/medline PY - 2005/8/30/entrez SP - 2141 EP - 9 JF - European journal of cancer (Oxford, England : 1990) JO - Eur. J. Cancer VL - 41 IS - 14 N2 - A large European case-control study investigated the association between sunbed use and cutaneous melanoma in an adult population aged between 18 and 49 years. Between 1999 and 2001 sun and sunbed exposure was recorded in 597 newly diagnosed melanoma cases and 622 controls in Belgium, France, The Netherlands, Sweden and the UK. Fifty three percent of cases and 57% of controls ever used sunbeds. The overall adjusted odds ratio (OR) associated with ever sunbed use was 0.90 (95% CI: 0.71-1.14). There was a South-to-North gradient with high prevalence of sunbed exposure in Northern Europe and lower prevalence in the South (prevalence of use in France 20%, OR: 1.19 (0.68-2.07) compared to Sweden, prevalence 83%, relative risk 0.62 (0.26-1.46)). Dose and lag-time between first exposure to sunbeds and time of study were not associated with melanoma risk, neither were sunbathing and sunburns (adjusted OR for mean number of weeks spent in sunny climates >14 years: 1.12 (0.88-1.43); adjusted OR for any sunburn >14 years: 1.16 (0.9-1.45)). Host factors such as numbers of naevi and skin type were the strongest risk indicators for melanoma. Public health campaigns have improved knowledge regarding risk of UV-radiation for skin cancers and this may have led to recall and selection biases in both cases and controls in this study. Sunbed exposure has become increasingly prevalent over the last 20 years, especially in Northern Europe but the full impact of this exposure on skin cancers may not become apparent for many years. SN - 0959-8049 UR - https://www.unboundmedicine.com/medline/citation/16125927/A_multicentre_epidemiological_study_on_sunbed_use_and_cutaneous_melanoma_in_Europe_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0959-8049(05)00544-7 DB - PRIME DP - Unbound Medicine ER -